Christopher Sinpraseuth
This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Christopher Sinpraseuth, a licensed Representative with CE reference AQU096. Currently licensed at 1 firm(s): Arrowpoint Investment Partners (Hong Kong) Limited. Active regulated activities: Type 9 - Asset management. This person has 14.8 years of SFC licence history. Total licence records on file: 12.
Information
- LinkedIn:
- Email:
Licence history
| Firm | Role | Regulated activity | From | To |
|---|---|---|---|---|
| Arrowpoint Investment Partners (Hong Kong) Limited | Rep | Type 9 - Asset management | 2024-06-26 | present |
| Ovata Capital Management Limited 歐萬達基金管理有限公司 |
Rep | Type 9 - Asset management | 2017-11-06 | 2022-01-31 |
| BlueCrest Capital Management (Hong Kong) Limited | RO | Type 1 - Dealing in securities | 2017-01-20 | 2017-03-31 |
| BlueCrest Capital Management (Hong Kong) Limited | RO | Type 2 - Dealing in futures contracts | 2017-01-20 | 2017-03-31 |
| BlueCrest Capital Management (Hong Kong) Limited | Rep | Type 1 - Dealing in securities | 2015-04-01 | 2017-01-20 |
| BlueCrest Capital Management (Hong Kong) Limited | Rep | Type 2 - Dealing in futures contracts | 2015-04-01 | 2017-01-20 |
| BlueCrest Capital Management (Hong Kong) Limited | Rep | Type 9 - Asset management | 2015-03-04 | 2017-03-31 |
| Barclays Capital Asia Limited 巴克萊亞洲有限公司 |
Rep | Type 2 - Dealing in futures contracts | 2012-07-24 | 2014-11-19 |
| Barclays Capital Asia Limited 巴克萊亞洲有限公司 |
Rep | Type 1 - Dealing in securities | 2011-05-18 | 2014-11-19 |
| ConvergEx Asia Pacific Limited | Rep | Type 1 - Dealing in securities | 2010-12-21 | 2011-04-08 |
| BOCI Securities Limited 中銀國際證券有限公司 |
Rep | Type 1 - Dealing in securities | 2009-01-29 | 2010-10-30 |
| CLSA Limited 中信里昂證券有限公司 |
Rep | Type 1 - Dealing in securities | 2008-04-01 | 2009-01-23 |
Worked alongside
The 20 closest colleagues, strongest tie first — individuals licensed at the same firm as Christopher Sinpraseuth during overlapping periods. Ranked by how long they overlapped and how similar their regulated activities were, with shared time at a smaller firm weighted more than at a large one. See the detailed formula.